Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 First Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 131 % -4.83%
Quick Ratio 25.2 % +20.7%
Debt-to-equity -730 % +51.5%
Return On Equity 130 % -55.7%
Return On Assets -20.6 % +1.25%
Operating Margin -20.5 % +24.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 218M shares +15.9%
Common Stock, Shares, Outstanding 212M shares +12.3%
Entity Public Float 170M USD +165%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 210M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 210M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 170M USD -12.5%
Cost of Revenue 61.5M USD +16.4%
Research and Development Expense 35.7M USD -58.1%
Operating Income (Loss) -34.8M USD +33.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46M USD -38.3%
Net Income (Loss) Attributable to Parent -46M USD +21.5%
Earnings Per Share, Basic -0.22 USD/shares +33.3%
Earnings Per Share, Diluted -0.22 USD/shares +31.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34M USD -26.9%
Accounts Receivable, after Allowance for Credit Loss, Current 32.2M USD +42.4%
Inventory, Net 20.5M USD +11.1%
Other Assets, Current 6.21M USD
Assets, Current 100M USD -8.65%
Property, Plant and Equipment, Net 2.53M USD -37%
Operating Lease, Right-of-Use Asset 9.3M USD -30.7%
Intangible Assets, Net (Excluding Goodwill) 9.01M USD -80%
Goodwill 59M USD 0%
Other Assets, Noncurrent 27.1M USD +603%
Assets 207M USD -11.9%
Accounts Payable, Current 13.5M USD +49.3%
Employee-related Liabilities, Current 7.57M USD +5.01%
Accrued Liabilities, Current 52.2M USD -16.7%
Contract with Customer, Liability, Current 43.3M USD
Liabilities, Current 65.7M USD -17.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 4.94M USD -51.7%
Other Liabilities, Noncurrent 4.73M USD -49.8%
Liabilities 258M USD -6.15%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD 0%
Retained Earnings (Accumulated Deficit) -1.66B USD -2.86%
Stockholders' Equity Attributable to Parent -50.4M USD -27.9%
Liabilities and Equity 207M USD -11.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.4M USD -10.8%
Net Cash Provided by (Used in) Financing Activities 18.5M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 212M shares +12.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -957K USD +97.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.7M USD -25.9%
Deferred Tax Assets, Valuation Allowance 365M USD +1.31%
Deferred Tax Assets, Gross 377M USD -1.86%
Operating Lease, Liability 10.2M USD -32.2%
Depreciation 364K USD -8.54%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46M USD +21.5%
Lessee, Operating Lease, Liability, to be Paid 10.9M USD -34.5%
Property, Plant and Equipment, Gross 14.5M USD +0.79%
Operating Lease, Liability, Current 5.29M USD +8.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.61M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.82M USD +1.36%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 646K USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD -56.4%
Deferred Tax Assets, Operating Loss Carryforwards 289M USD +0.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.57M USD -60.9%
Operating Lease, Payments 5.6M USD -11.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 36M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -50.4%
Share-based Payment Arrangement, Expense 7.59M USD -9.76%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%